Advent Life Sciences
Overview
Advent Life Sciences is a venture capital firm dedicated to investing in life sciences businesses . Focusing on innovative companies in biotechnology, pharmaceuticals, medical devices, and diagnostics, Advent Life Sciences supports the development of breakthrough technologies and therapies . By providing capital and strategic expertise, the firm helps entrepreneurs navigate the complexities of the life sciences sector, accelerating the path from research to market . Advent Life Sciences is committed to advancing healthcare solutions that improve patient outcomes and address unmet medical needs globally . They invest in early and mid-stage companies with a first-in-class or best-in-class approach . Their investments are focused on new drug discovery, including small molecules, biologics, and new modalities, as well as med tech, enabling technologies, and vaccines .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beacon Therapeutics | Jan 2026 | Series C | Co-investor |
| AviadoBio | Dec 2021 | Series A | Co-investor |
| Artax Biopharma | Aug 2024 | Convertible Debt | Co-investor |
| Rappta Therapeutics | Oct 2020 | Series A | Co-investor |
| Arrakis Therapeutics | Apr 2019 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Raj Parekh
General Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Advent Life Sciences based?
Advent Life Sciences is headquartered in London, England, United Kingdom.
When was Advent Life Sciences founded?
Advent Life Sciences was founded in 2006.
How many portfolio companies does Advent Life Sciences have?
Advent Life Sciences has 26 portfolio companies in Caplight's dataset.
What are some companies in Advent Life Sciences's portfolio?
Portfolio companies visible on Caplight include Beacon Therapeutics, AviadoBio, Artax Biopharma, Rappta Therapeutics, Arrakis Therapeutics.
What was Advent Life Sciences's most recent investment shown here?
Advent Life Sciences's most recent investment in this portfolio sample was in Beacon Therapeutics in 2026.
What sectors does Advent Life Sciences focus on?
Advent Life Sciences focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software.
What company stages does Advent Life Sciences focus on?
Advent Life Sciences typically invests at the MultiStage stage.
What is Advent Life Sciences's AUM?
Advent Life Sciences's assets under management are estimated between $250.0M and $500.0M.